FDA Inspection 614298 — Morton Grove Pharmaceuticals, Inc.

Morton Grove Pharmaceuticals, Inc. — FEI 1420913

The FDA completed an inspection of Morton Grove Pharmaceuticals, Inc. on Sep 17, 2009 in Morton Grove, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 17, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Morton Grove, IL (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.